Janux Therapeutics Inc. (JANX) NASDAQ

$10.91 -0.04 (-0.36%)

Market Cap: $454.18M

As of 05/25/22 04:00 PM EDT. Market closed.

(JANX)

Janux Therapeutics Inc. (JANX) NASDAQ

$10.91 -0.04 (-0.36%)

Market Cap: $454.18M

As of 05/25/22 04:00 PM EDT. Market closed.

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
16
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$10.95
Days Range
$10.79 - $11.20
52 week range
$9.39 - $37.99
Volume
35,713
Avg. Volume (30 days)
92,102
Market Cap
$454.18M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
41,629,367
Open
$0
Previous Close
$10.95
Days Range
$10.79 - $11.20
52 week range
$9.39 - $37.99
Volume
35,713
Avg. Volume (30 days)
92,102
Market Cap
$454.18M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
41,629,367

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR JANUX THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
ORBIMED ADVISORS LLC Director Dec 29, 2021 Sale $20.30 40,400 820,120 2,258,566 Dec 30, 2021, 09:00 PM
Thompson Peter A. Director Dec 29, 2021 Sale $20.30 40,400 820,120 2,258,566 Dec 30, 2021, 08:55 PM
ORBIMED ADVISORS LLC Director Dec 21, 2021 Sale $19.00 119,400 2,268,600 2,295,266 Dec 23, 2021, 04:13 PM
Thompson Peter A. Director Dec 21, 2021 Sale $19.00 119,400 2,268,600 2,295,266 Dec 23, 2021, 04:08 PM
Thompson Peter A. Director Dec 16, 2021 Sale $19.07 393,300 7,500,231 2,403,566 Dec 17, 2021, 05:16 PM
ORBIMED ADVISORS LLC Director Dec 16, 2021 Sale $19.07 393,300 7,500,231 2,403,566 Dec 17, 2021, 05:13 PM
Thompson Peter A. Director Jun 15, 2021 Buy $17.00 705,853 11,999,501 2,760,366 Jun 16, 2021, 06:20 PM
Reardon Tighe Acting Chief Financial Officer Jun 15, 2021 Buy $17.00 629,411 10,699,987 4,479,492 Jun 16, 2021, 06:11 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
ORBIMED ADVISORS LLC Director 12/29/2021 820,120
Thompson Peter A. Director 12/29/2021 820,120
ORBIMED ADVISORS LLC Director 12/21/2021 2,268,600
Thompson Peter A. Director 12/21/2021 2,268,600
Thompson Peter A. Director 12/16/2021 7,500,231
ORBIMED ADVISORS LLC Director 12/16/2021 7,500,231
Thompson Peter A. Director 06/15/2021 11,999,501
Reardon Tighe Acting Chief Financial Officer 06/15/2021 10,699,987
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
-2.67%
1Q
12/31/2021
06/30/2021
-0.48%
2Q

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
-2.67%
1Q
06/30/2021
-0.48%
2Q